Ethoxysanguinarine Induces Apoptosis, Inhibits Metastasis and Sensitizes cells to Docetaxel in Breast Cancer Cells through Inhibition of Hakai

Ethoxysanguinarine (ESG) is a benzophenanthridine alkaloid extracted from plants of Papaveraceae family, such as Macleaya cordata (Willd) R. Br. The anti‐cancer activity of ESG has been rarely reported. In this study, we investigated the anti‐breast cancer effect of ESG and its underlying mechanism....

Full description

Saved in:
Bibliographic Details
Published inChemistry & biodiversity Vol. 20; no. 2; pp. e202200284 - n/a
Main Authors Ma, Liang, Xuan, Xiao‐Jing, Chen, Xue‐Ming, Fan, Ming‐Hui, Liu, Jian, Huang, Guo‐Zheng, Liu, Zi
Format Journal Article
LanguageEnglish
Published Switzerland Wiley Subscription Services, Inc 01.02.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Ethoxysanguinarine (ESG) is a benzophenanthridine alkaloid extracted from plants of Papaveraceae family, such as Macleaya cordata (Willd) R. Br. The anti‐cancer activity of ESG has been rarely reported. In this study, we investigated the anti‐breast cancer effect of ESG and its underlying mechanism. MTT assay and flow cytometry analysis showed that ESG inhibited the viability and induced apoptosis in MCF7 and MDA‐MB‐231 human breast cancer cells. Western blot revealed that ESG triggered intrinsic and extrinsic apoptotic pathways, as evidenced by the activation of caspase‐8, caspase‐9 and caspase‐3. ESG attenuated breast cancer cell migration and invasion through Hakai/E‐cadherin/N‐cadherin. Moreover, Hakai knockdown sensitized ESG‐triggered viability and motility inhibition, suggesting that Hakai mediated the anti‐breast cancer effect of ESG. In addition, ESG potentiated the anti‐cancer activity of docetaxel (DTX) in breast cancer cells. Overall, our findings demonstrate that ESG exhibits outstanding pro‐apoptosis and anti‐metastasis effects on breast cancer via a mechanism related to Hakai‐related signaling pathway.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1612-1872
1612-1880
DOI:10.1002/cbdv.202200284